Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer
Open Access
- 24 April 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (9) , 2391
Abstract
Chronic obstructive pulmonary disease (COPD) is associated with a poor prognosis in patients with non-small cell lung cancer (NSCLC). However, the impact of COPD treatment on the survival of patients with advanced NSCLC remains uncertain. We retrospectively investigated COPD patients among patients newly diagnosed with advanced NSCLC between September 2005 and August 2019 at a university hospital. The clinical characteristics, lung function, and survival outcomes were analyzed and compared between patients who did and did not receive COPD treatment. Among 221 patients with advanced NSCLC and COPD, 124 patients received treatment for COPD and 97 patients did not receive treatment for COPD. Forced expiratory volume in 1 s (FEV1) % predicted value was greater in the no-treatment group than in the COPD treatment group (p < 0.001). The median overall survival (OS) of the treatment group was 10.7 months, while that of the no-treatment group was 8.7 months (p = 0.007). In the multivariate analysis, COPD treatment was independently associated with improved OS (hazard ratio 0.71, 95% confidence interval 0.53–0.95, and p = 0.021). COPD treatment was associated with improved OS in patients with advanced NSCLC and COPD. Therefore, pretreatment spirometry and maximal treatment for COPD may offer a chance of optimal management for patients with advanced NSCLC.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trialEuropean Journal of Cardio-Thoracic Surgery, 2011
- Forced Expiratory Volume in One Second as a Prognostic Factor in Advanced Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumoniaEuropean Respiratory Journal, 2010
- Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: A prognostic score from individual data of nine randomised trialsEuropean Journal of Cancer, 2010
- Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespiratory Research, 2009
- COPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEuropean Respiratory Journal, 2009
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbationThorax, 2006
- Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantationTransplantation and Cellular Therapy, 2001